ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1070

Discordance of Patient, Physician and Nurse Practitioner Assessment of Disease Burden in Systemic Sclerosis

Maylen Nordgård Carstens1, Håvard Fretheim1, Imon Barua1, Henriette Didriksen2, Torhild Garen1, Øyvind Midtvedt1, Øyvind Molberg3 and Anna-Maria Hoffmann-Vold1, 1Oslo University Hospital, Oslo, Norway, 2Oslo University Hospital, Moss, Norway, 3Department of Rheumatology, Oslo University Hospital, Oslo, Norway, Oslo, Norway

Meeting: ACR Convergence 2022

Keywords: Cohort Study, Disability, Systemic sclerosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2022

Title: Systemic Sclerosis and Related Disorders – Clinical Poster I

Session Type: Poster Session B

Session Time: 9:00AM-10:30AM

Background/Purpose: Assessment of disease burden is crucial in the management of systemic sclerosis (SSc). The patient global assessment (PatGA) is a patient self-reported measure widely used in SSc. It should reflect the patient’s own assessment of the impact of their condition. The Physician’s Global Assessment (PhyGA) is a measure used by physicians to determine the patient’s overall disease burden. Nurses are distinct from other healthcare providers as they have a wide scope of practice and approach to medical care. They play an integral role in promoting health, preventing illness, and caring for all individuals, including those who are disabled or are physically or mentally ill. However, to date the nurse global assessment (NurGA) has not been assessed. The objective of our study was to assess patient, physician and nurse assessments of disease burden of SSc patients and their agreement.

Methods: We included SSc patients from the Oslo University Hospital (OUH). The PatGA, PhyGa and NurGA were assessed on 100-mm Visual Analogue Scales (VAS) on the same day at an outpatient visit between January 2021 and February 2022. In total, two physicians and one nurse assessed all SSc patients. We evaluated agreement between Pat, Phy and NurGA using descriptive statistics and correlation analyses.

Results: We evaluated 55 SSc patients, including 6 (11%) diffuse, 47 (85%) limited cutaneous SSc patients and 2 (4%) patients with SSc overlap syndrome; 51 (93%) were females with mean age of 59 years (Table). Organ manifestations are shown in the table. The overall disease burden assessed by patients, physicians and the nurse is shown in Figure 1. Both physicians and the nurse assessed the disease burden significantly worse compared to the patients, with less differences between the patients and the nurse (Figure 1). The correlation between the disease burden assessed by physicians and patients was only weak, while moderate between patients and the nurse and the nurse and physicians (Figure 2).

Conclusion: The discordance and low correlations between Pat, Nur and PhyGA suggest that global assessments of disease burden in patients with multiorgan diseases should include more comprehensive assessments. It also highlights the distinct role of the nurse from other healthcare providers supporting their central role in the management of patients with SSc.

Supporting image 1

Table1: Clinical characteristics and demographics of included SSc patients

Supporting image 2

Figure 1: Mean levels of global assessments of disease burden assessed by physician, nurse and patients

Supporting image 3

Figure 2: Correlation of global assessments of disease burden assessed by physician, nurse and patients


Disclosures: M. Nordgård Carstens, None; H. Fretheim, Bayer, GSK and Actelion; I. Barua, None; H. Didriksen, None; T. Garen, None; Ø. Midtvedt, Jannsen, Boehringer-Ingelheim; Ø. Molberg, None; A. Hoffmann-Vold, Boehringer-Ingelheim, Janssen, Eli Lilly, Merck/MSD, Roche.

To cite this abstract in AMA style:

Nordgård Carstens M, Fretheim H, Barua I, Didriksen H, Garen T, Midtvedt Ø, Molberg Ø, Hoffmann-Vold A. Discordance of Patient, Physician and Nurse Practitioner Assessment of Disease Burden in Systemic Sclerosis [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/discordance-of-patient-physician-and-nurse-practitioner-assessment-of-disease-burden-in-systemic-sclerosis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/discordance-of-patient-physician-and-nurse-practitioner-assessment-of-disease-burden-in-systemic-sclerosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology